In response to local low-dose IR, Inducible nitric oxide synthase (iNOS)+ M1-like macrophages undergo differentiation, allowing the recruitment of tumor-specific T-cells and promoting tumor regression in human pancreatic carcinomas [110,115]. The gene discussed is NOS2; the disease is exocrine pancreatic carcinoma.